178 related articles for article (PubMed ID: 17393120)
41. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.
Zhou L; Li X; Zhou F; Jin Z; Chen D; Wang P; Zhang S; Zhuge Y; Shang Y; Zou X
Cancer Sci; 2018 Apr; 109(4):1044-1054. PubMed ID: 29450946
[TBL] [Abstract][Full Text] [Related]
42. The evaluation of ghrelin mRNA expression in human somatotroph adenomas.
Wasko R; Jaskuła M; Plewa R; Komarowska H; Poreba E; Goździcka-Józefiak A; Liebert W; Bednarek J; Sowiński J
Neuro Endocrinol Lett; 2006; 27(1-2):169-73. PubMed ID: 16648773
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.
Danila DC; Zhang X; Zhou Y; Haidar JN; Klibanski A
J Clin Endocrinol Metab; 2002 Oct; 87(10):4741-6. PubMed ID: 12364468
[TBL] [Abstract][Full Text] [Related]
44. LRIG1 enhances cisplatin sensitivity of glioma cell lines.
Wang X; Xiao Q; Xing X; Tian C; Zhang H; Ye F; Wan F; Wang B; Guo D; Lei T
Oncol Res; 2012; 20(5-6):205-11. PubMed ID: 23581227
[TBL] [Abstract][Full Text] [Related]
45. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
Wang M; Zhang H; Heng X; Pang Q; Sun A
Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
[TBL] [Abstract][Full Text] [Related]
46. LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor.
Wang Y; Poulin EJ; Coffey RJ
Br J Cancer; 2013 May; 108(9):1765-70. PubMed ID: 23558895
[TBL] [Abstract][Full Text] [Related]
47. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
[TBL] [Abstract][Full Text] [Related]
48. The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors.
Musat M; Korbonits M; Pyle M; Gueorguiev M; Kola B; Morris DG; Powell M; Dumitrache C; Poiana C; Grossman AB
Pituitary; 2002; 5(4):235-42. PubMed ID: 14558671
[TBL] [Abstract][Full Text] [Related]
49. Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1.
Yi W; Holmlund C; Nilsson J; Inui S; Lei T; Itami S; Henriksson R; Hedman H
Exp Cell Res; 2011 Feb; 317(4):504-12. PubMed ID: 21087604
[TBL] [Abstract][Full Text] [Related]
50. Estrogen receptor beta mRNA expression in normal and adenomatous pituitaries.
Gittoes NJ; McCabe CJ; Sheppard MC; Franklyn JA
Pituitary; 1999; 1(2):99-104. PubMed ID: 11081187
[TBL] [Abstract][Full Text] [Related]
51. Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.
Thomasson M; Hedman H; Ljungberg B; Henriksson R
BMC Res Notes; 2012 May; 5():216. PubMed ID: 22554477
[TBL] [Abstract][Full Text] [Related]
52. Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.
Piekielko-Witkowska A; Kedzierska H; Poplawski P; Wojcicka A; Rybicka B; Maksymowicz M; Grajkowska W; Matyja E; Mandat T; Bonicki W; Nauman P
Biochim Biophys Acta; 2013 Jun; 1832(6):763-72. PubMed ID: 23462647
[TBL] [Abstract][Full Text] [Related]
53. LRIG1 expression in colorectal cancer.
Ljuslinder I; Golovleva I; Palmqvist R; Oberg A; Stenling R; Jonsson Y; Hedman H; Henriksson R; Malmer B
Acta Oncol; 2007; 46(8):1118-22. PubMed ID: 17851870
[TBL] [Abstract][Full Text] [Related]
54. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
55. Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro.
Wang B; Han L; Chen R; Cai M; Han F; Lei T; Guo D
Cancer Biol Ther; 2009 Jun; 8(11):1018-23. PubMed ID: 19421009
[TBL] [Abstract][Full Text] [Related]
56. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
Alexander JM; Swearingen B; Tindall GT; Klibanski A
J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
[TBL] [Abstract][Full Text] [Related]
57. Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.
Yoshida D; Teramoto A
Cell Adh Migr; 2007; 1(1):43-51. PubMed ID: 19262092
[TBL] [Abstract][Full Text] [Related]
58. TFF3 knockout in human pituitary adenoma cell HP75 facilitates cell apoptosis via mitochondrial pathway.
Gao F; Pan S; Liu B; Zhang H
Int J Clin Exp Pathol; 2015; 8(11):14568-73. PubMed ID: 26823779
[TBL] [Abstract][Full Text] [Related]
59. LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance.
Billing O; Holmgren Y; Nosek D; Hedman H; Hemmingsson O
Oncogene; 2021 May; 40(21):3707-3718. PubMed ID: 33947959
[TBL] [Abstract][Full Text] [Related]
60. The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea.
Guo D; Holmlund C; Henriksson R; Hedman H
Genomics; 2004 Jul; 84(1):157-65. PubMed ID: 15203213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
